Clinical Trial Update: Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

View source ↗

Summary

The study evaluating non-invasive diagnostics and monitoring of minimal residual disease and clonal evolution in Waldenström macroglobulinemia and IgM monoclona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Igm Monoclonal Gammopathy of Undetermined Significance
• Waldenström Macroglobulinemia

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Waldenstrom Macroglobulinemia | Status: COMPLETED